Oct 5, 2025
6
min read
Medically Reviewed
Share
Understanding the Probabilistic Nature of AI
To critically appraise an AI assistant, one must first understand what it is doing. Large Language Models (LLMs), which underpin most modern clinical AI tools, do not "know" medicine in the way a human doctor does. They do not possess a conceptual understanding of physiology or pathology. Instead, they are probabilistic engines. They have been trained on vast datasets of text to predict the most likely next word or phrase in a sequence. When an AI suggests a differential diagnosis or a billing code, it is calculating a statistical probability based on patterns it has seen before.
This distinction is vital because it explains why AI can be incredibly accurate one moment and confidently wrong the next—a phenomenon known as "hallucination." A standalone AI scribe might hear a patient mention "chest pain" and, based on statistical probability, suggest a protocol for myocardial infarction. However, the human doctor, noticing the patient’s movement and history of recent gym injury, recognises it as musculoskeletal. Critical appraisal begins with this skepticism. The GP must view the AI’s output not as a definitive answer, but as a drafted suggestion derived from pattern matching. In a unified platform like MediQo, this appraisal is supported by the system’s design. The Clinical Assistant does not present its output as a diagnosis; it presents it as "alternate considerations" or "contextual insights." This framing encourages the doctor to engage their critical faculties rather than passively accepting the text.
Context as the Primary Filter for Appraisal
The most effective tool for appraising AI output is context. An AI suggestion that seems reasonable in isolation may be absurd when the patient’s full history is considered. Standalone AI tools often fail this test because they lack historical data. They listen to the fifteen minutes of conversation in the room but are blind to the ten years of history in the file. This forces the GP to perform a heavy mental cross-reference to validate the AI’s suggestions.
A unified clinical automation platform dramatically reduces the effort required for this validation by embedding context into the workflow. MediQo’s architecture ensures that the Clinical Assistant is informed by the entire patient journey. It begins with CALLA, the AI telephony module. When a patient books an appointment, CALLA captures structured pre-visit intake data and conversational intent. This information flows into the History-at-a-Glance timeline, along with medication history and previous flags. When the AI offers a suggestion during the consult, it has already factored in this data. For the GP, critical appraisal becomes a process of verifying that the AI has synthesised the known facts correctly. If the AI suggests a medication that conflicts with an allergy listed in the unified record, the discrepancy is easier to spot because the data sources are connected. The platform empowers the doctor to ask: "Does this recommendation align with what we already know about this patient?"
Expert Tips
"The mindset of the modern GP needs to shift from 'creator' to 'curator.' In the past, your value was in holding all the information in your head and writing it down. Now, your value is in your judgement—your ability to look at the information the AI presents and say, 'That fits,' or 'That doesn't make sense.' You are no longer the typist; you are the editor-in-chief. A unified platform like MediQo gives you the editorial tools you need—the context, the history, and the clarity—to make those judgements quickly and safely. Trust the platform to do the work, but trust yourself to make the decisions." — Arash Zohuri, CEO, MediQo
Evaluating Alignment with Australian Clinical Guidelines
One of the subtle risks of using global AI models is their training data. Many Large Language Models are heavily trained on North American medical literature. Consequently, a standalone AI tool might suggest a treatment pathway or a medication brand name that is standard in the United States but inappropriate or unavailable in Australia. It might reference blood glucose in mg/dL rather than mmol/L, or suggest screening protocols that differ from local standards.
Critical appraisal for the Australian GP involves filtering these suggestions through the lens of local practice. When using MediQo, the Clinical Assistant is engineered to align with general clinical guidelines relevant to the Australian context. However, the doctor must still remain vigilant. When the system automates a care plan or drafts a referral, the GP should scan for tell-tale signs of jurisdictional misalignment. Is the terminology consistent with Australian nomenclature? Does the suggested management plan adhere to the local therapeutic frameworks? By using a platform hosted in Australia and designed for the local market, the frequency of these "cultural" errors is reduced, but the responsibility to verify remains. The doctor’s role is to act as the localization filter, ensuring that the probabilistic output of the AI adheres to the strict standards of Australian general practice.
Key Takeaways
Always verify AI output against your clinical knowledge and official guidelines.
Be vigilant for AI "hallucinations"—plausible-sounding but incorrect information.
Treat AI as a clinical decision support tool, not the ultimate source of truth.
Cross-check references and citations provided by the AI assistant for accuracy.
The introduction of Artificial Intelligence (AI) into the consulting room represents the most significant shift in general practice since the digitisation of medical records. Australian General Practitioners are increasingly turning to AI-powered tools to alleviate the crushing administrative burden of documentation, care planning, and billing. However, as these systems evolve from simple transcription tools into sophisticated clinical assistants capable of offering "augmented analysis," a new core competency is required of the clinician. That competency is critical appraisal. Just as a doctor would not accept the results of a clinical trial without scrutinising the methodology, sample size, and potential bias, they must not accept the output of an AI assistant without a rigorous evaluation process.
The danger in the current market lies in the "black box" nature of many standalone AI applications. These tools often operate in a vacuum, listening to a consultation without any knowledge of the patient’s history or the clinic’s specific context. They generate suggestions that may look plausible on the surface but crumble under scrutiny. To safely leverage the power of AI, clinicians must understand the mechanism of the machine and insist on a workflow that facilitates transparency. This article argues that the ability to critically appraise AI recommendations is enhanced significantly when using a unified clinical automation platform. By consolidating the patient’s narrative—from the initial phone call to the final billing code—under one digital roof, platforms like MediQo provide the context necessary for doctors to validate AI insights efficiently and safely.
Share